Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$57,188,826
+$14,110,480 QoQ
Shares Held
47,680
+1.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
6.06%
of 13F equity value
Holder Rank
#513
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $135,758,423 across 9 Drug Manufacturers - General names. LLY ranks #1 (42.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
47,680 | $57,188,826 | |
| 2 | ABBV |
AbbVie Inc.
|
111,026 | $27,938,581 | |
| 3 | JNJ |
Johnson & Johnson
|
82,604 | $20,978,936 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,260 | $8,000,410 | |
| 5 | AMGN |
Amgen Inc
|
18,021 | $6,525,764 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
47,312 | $5,977,398 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
84,745 | $4,883,006 | |
| 8 | PFE |
Pfizer Inc
|
138,473 | $3,334,429 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,188,826 | 47,680 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $43,078,346 | 46,836 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $52,442,238 | 48,798 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $39,227,356 | 51,412 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $40,601,819 | 52,085 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $43,252,906 | 52,370 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $41,543,636 | 53,813 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $48,592,036 | 54,848 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $50,941,204 | 56,265 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $45,460,870 | 58,436 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $33,758,062 | 57,912 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $32,240,690 | 60,024 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $28,614,813 | 61,015 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $21,126,510 | 61,518 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $25,671,724 | 70,172 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $23,705,111 | 73,311 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $24,726,427 | 76,262 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $23,077,412 | 80,586 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $22,322,718 | 80,815 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $18,858,298 | 81,620 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $18,851,624 | 82,135 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $15,434,507 | 82,617 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $14,116,879 | 83,611 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $12,093,675 | 81,703 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $13,533,849 | 82,433 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $11,522,359 | 83,062 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||